{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:56:10Z","timestamp":1759341370899},"reference-count":11,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2001,12,21]],"date-time":"2001-12-21T00:00:00Z","timestamp":1008892800000},"content-version":"vor","delay-in-days":234,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tropical Med Int Health"],"published-print":{"date-parts":[[2001,5]]},"abstract":"<jats:p>CGP 40\u2003215 is an inhibitor of <jats:italic>S<\/jats:italic>\u2010adenosylmethionine decarboxylase, a key enzyme in trypanosomal polyamine biosynthesis. It is highly active against <jats:italic>Trypanosoma brucei rhodesiense<\/jats:italic> and <jats:italic>T. b. gambiense in vitro<\/jats:italic> and in the corresponding rodent models, and therefore was a promising candidate for further development as a new drug against human African trypanosomiasis. We conducted initial pharmacokinetic and efficacy studies in African green monkeys: based on two dose\u2010finding studies, an infection\u2010treatment and a pharmacokinetic study in eight monkeys infected with <jats:italic>T. b. rhodesiense<\/jats:italic> in the 1st stage of infection. PK analysis revealed curative drug levels in the serum but complete absence of the drug in the cerebrospinal fluid. No adverse effects of the drug were observed, although in rats CGP 40\u2003215 had caused hypotension. The following PK parameters were calculated using a two\u2010compartment model: <jats:italic>t<\/jats:italic><jats:sub>1\/2<\/jats:sub>=1.8\u2003h, <jats:italic>V<\/jats:italic><jats:sub>SS<\/jats:sub>\/<jats:italic>f<\/jats:italic>=0.4\u2003l\/kg, CL\/<jats:italic>f<\/jats:italic>=3.0\u2003ml\/min\u2003\u00d7\u2003kg and AUC=21\u2003900\u2003ng\u2003\u00d7\u2003h\/ml. Six of the eight monkeys were cured, one animal relapsed on day\u2003222 and one animal died of unknown reasons, but was aparasitaemic. The study confirmed the curative potential of CGP 40\u2003215 for 1st stage <jats:italic>T. b. rhodesiense<\/jats:italic> infection. Unfortunately, it was also found that the compound did not pass the blood\u2013brain barrier, a pre\u2010requisite for cure of 2nd stage (CNS) infection. As the majority of sleeping sickness patients seeking treatment are in the 2nd stage of the disease, further development of the compound was stopped.<\/jats:p>","DOI":"10.1046\/j.1365-3156.2001.00728.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T21:37:30Z","timestamp":1047505050000},"page":"362-368","source":"Crossref","is-referenced-by-count":12,"title":["The story of CGP 40\u2003215: studies on its efficacy and pharmacokinetics in African green monkey infected with <i>Trypanosoma brucei rhodesiense<\/i>"],"prefix":"10.1111","volume":"6","author":[{"given":"R.","family":"Brun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Burri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. W.","family":"Gichuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,21]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.6.1448"},{"key":"e_1_2_7_3_2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/00034983.1989.11812414","article-title":"Treatment of arsenical refractory Rhodesian sleeping sickness in Kenya","volume":"83","author":"Bales JDJ","year":"1989","journal-title":"Annals of Tropical Medicine and Parasitology"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1985.tb03772.x"},{"key":"e_1_2_7_5_2","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1128\/AAC.40.6.1442","article-title":"In vitro trypanocidal activities of new S\u2010adenosylmethionine decarboxylase inhibitors","volume":"40","author":"Brun R","year":"1996","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"e_1_2_7_6_2","first-page":"223","article-title":"An in vitro bioassay for quantification of melarsoprol in serum and cerebrospinal fluid","volume":"43","author":"Burri C","year":"1992","journal-title":"Tropical Medicine and Parasitology"},{"key":"e_1_2_7_7_2","unstructured":"HeinzelG WoloszczakR ThomannP(1993)TOPFIT \u2013 Pharmacokinetic and Pharmacodynamic Data Analysis System. Gustav Fischer\u2010Verlag Stuttgart."},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0001-706X(93)90083-N"},{"key":"e_1_2_7_9_2","first-page":"190","article-title":"Innate lack of susceptibility of Ugandan Trypanosoma brucei rhodesiense to DL\u2010alpha\u2010difluoromethylornithine (DFMO)","volume":"46","author":"Iten M","year":"1995","journal-title":"Tropical Medicine and Parasitology"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(99)90151-7"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-706X(99)00080-7"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.2001.00724.x"}],"container-title":["Tropical Medicine &amp; International Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-3156.2001.00728.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-3156.2001.00728.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T18:18:02Z","timestamp":1697566682000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-3156.2001.00728.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["10.1046\/j.1365-3156.2001.00728.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-3156.2001.00728.x","archive":["Portico"],"relation":{},"ISSN":["1360-2276","1365-3156"],"issn-type":[{"value":"1360-2276","type":"print"},{"value":"1365-3156","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,5]]}}}